MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotection effects of probiotics strains on a chronic MPTP-induced mouse model of Parkinson’s disease

Y. Qian, X. Yang, S. Xu, Q. Xiao (Shanghai, China)

Meeting: 2018 International Congress

Abstract Number: 1720

Keywords: Alpha-synuclein, Inflammation, Microglial activation

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To explore the effects of probiotics strains on the neuroinflammation and degeneration of dopaminergic neurons in chronic Parkinson’s disease (PD) mice model.

Background: Microglia-mediated neuroinflammation has been implicated in the pathogenesis of PD. A growing body of evidences from both the clinical and animals’ experiments suggested that gut microbiota dysbiosis play a key role in influencing the progress of PD. However, the potential role of the therapeutic options probiotics, which pointed at modification the gut microbiota composition in the progress of PD is unknown.

Methods: Four-week-old C57BL/6N male mice were oral-administered the probiotics strains Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019 (109 CFU/day) or saline for 4 weeks prior to testing. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (25 mg/kg) or saline were injected twice a week for 5 weeks. Mice were also oral-administered the probiotics or saline each day during the 5 weeks of MPTP injection. At the end of MPTP injection, gastrointestinal (fecal pellet output) and motor symptoms (open-field and pole tests) was assessed. Pathology of α-synuclein, tyrosine hydroxylase (TH) neuron loss, inflammation and hallmarks of microglial phenotype from the middle brain were also analyzed. Fecal samples were collected and the DNA were extracted and performed 16S rRNA sequencing targeting V3-V4 region.

Results: The supplementary of probiotics could adjusted the changed-community of gut microbiota induced by MPTP, especially with decrease of genus prevotella, which was linked with chronic inflammatory conditions. Probiotics also significantly attenuated gastrointestinal and motor symptoms, along with the decrease of pro-inflammatory cytokines mRNA expression, TH-positive neuronal loss, TLR-2 expression and typical hallmarks of the pro-inflammatory (M1) activation of microglia. Additionally, probiotics upregulated the anti-inflammatory cytokines mRNA expression as well as increasing the expression of typical hallmarks of anti-inflammatory (M2) phenotype.

Conclusions: Overall, the supplementary of probiotics strains was essential for M2 microglia polarization by modifying gut microbiota, and therefore it has a potential role in the switch of microglia phenotypes to show neuroprotective effects in the pathogenesis of PD.

To cite this abstract in AMA style:

Y. Qian, X. Yang, S. Xu, Q. Xiao. Neuroprotection effects of probiotics strains on a chronic MPTP-induced mouse model of Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/neuroprotection-effects-of-probiotics-strains-on-a-chronic-mptp-induced-mouse-model-of-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotection-effects-of-probiotics-strains-on-a-chronic-mptp-induced-mouse-model-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley